Table: begin end state 1 26 signal peptide 27 40 non-cytoplasmic 41 64 transmembrane 65 74 cytoplasmic 75 94 transmembrane 95 95 non-cytoplasmic 96 119 transmembrane 120 130 cytoplasmic 131 148 transmembrane 149 164 non-cytoplasmic 165 192 transmembrane 193 206 cytoplasmic 207 228 transmembrane 229 232 non-cytoplasmic 233 252 transmembrane 253 256 cytoplasmic 257 296 transmembrane 297 313 non-cytoplasmic 314 335 transmembrane 336 352 cytoplasmic 353 384 transmembrane 385 395 non-cytoplasmic 396 422 transmembrane 423 433 cytoplasmic 434 434 non-cytoplasmic 435 460 transmembrane 461 468 non-cytoplasmic
Input: >SM_b20444 FitnessBrowser__Smeli:SM_b20444 MLLLVGSFLVLMLVGVPVAISMAAASVLYLVSYNVAPDIIAAQRMIAGVESFPLLAVPFF ILAGNLMNSAGVTGRIYSFAVALVGWMKGGLAQVNIVGSVIFSGMSGTALADAAGIGTIE IKAMKDHGYPVDAAVGVTAASATLGPIFPPSLPFVIYGMMANVSIGALFMAGVVPGVVMT VLMMLTVAIFAYKRGWGSDTPFEMKRLLAASLEVVVVLAVPLFIYLLMAAGLSMNLAVGI ALVVLLALDWYFDFSAVMALMTPIILIGGMTMGWFTPTEAAVAAVIWSLFLGLVRYRTMT MSTLARATFDTIETTASVLFIVTAASIFAWLLTVSQAAQMLSGAILTITDNKWVFLILVN LLMLFVGCFLDTIAAITILVPILLPLTAQFGIDPVHFGLIMTLNLMIGLLHPPLGMVLFV LSRVAKLSVERTTMAILPWLVPLFIALILITFVPAVVLWLPQSVGLIR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server